NYSE · Healthcare
LABCORP HOLDINGS INC. (LH)
As-reported financials and recent SEC filings for LABCORP HOLDINGS INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$13.95B
Net income
$876.5M
Net margin
6.3%
Diluted EPS
$10.46
ROE
10.2%
P/E (TTM)
24.0×
Market cap
$22.26B
Debt / equity
0.6×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2021 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B |
| Gross profit | $4.01B | $3.62B | $3.36B | $3.71B | $4.99B |
| Operating income | $1.38B | $1.09B | $725.6M | $1.44B | $3.05B |
| Net income | $876.5M | $746.0M | $418.0M | $1.28B | $2.38B |
| Diluted EPS | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-10
View on EDGAR →1442026-06-08
View on EDGAR →8-K2026-05-27
View on EDGAR →8-K2026-05-26
View on EDGAR →SD2026-05-22
View on EDGAR →42026-05-13
View on EDGAR →1442026-05-11
View on EDGAR →1442026-05-06
View on EDGAR →Go deeper on LH
Search LABCORP HOLDINGS INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.